title: Successful treatment of capture myopathy in three wild greater sandhill cranes (Grus canadensis tabida).
abstract: Two adult and 1 juvenile free-flying greater sandhill cranes (Grus canadensis tabida) were diagnosed with capture myopathy after alpha-chloralose baiting and physical capture during a banding and feeding ecologic study. Blood samples were collected for serum biochemical analysis at the time of capture for the 2 adults, and at 24 hours postcapture, at various intervals during treatment, and at the time of release for all 3 birds. Concentrations of creatine kinase, aspartate transaminase, and lactate dehydrogenase were high within 1 hour of capture and peaked approximately 3 days after capture. By days 10-17 after capture, creatine kinase and lactate dehydrogenase concentrations both decreased to within the reference range measured for cranes at capture, but aspartate transaminase concentrations remained 2-5 times higher than the measured reference range. Treatment consisted of corticosteroids, selenium/vitamin E, parenteral fluids, and gavage feedings. Physical therapy consisted of assisting the cranes to stand and walk 2-8 times a day, massaging leg muscles, and moving limbs manually through the range of motion. The adults were released when they were able to stand up independently and were pacing in the pen. The juvenile was released 12 hours after it was able to stand independently but was returned to the pen when it fell and could not rise. It was treated supportively for an additional 3 days and then successfully released. Both adult cranes were observed on their territories with their original mates after release and returned to their territories for the subsequent 8 years, raising chicks most years. After release, the juvenile was observed in a flock of cranes near its natal territory for the next 2 days.
authors: Department of Natural Resources, 2801 Progress Road, Madison, WI 53716, USA.
authors: Nancy K
authors: NK
authors: Businga
authors: Julie
authors: J
authors: Langenberg
authors: LaVinda
authors: L
authors: Carlson
mesh_terms: D000818:Animals; D000835:Animals, Wild; D001219:Aspartate Aminotransferases / Q000097:blood; D001715:Bird Diseases / Q000201:enzymology / Q000209:etiology / Q000628:therapy*; D001717:Birds / Q000097:blood; D002698:Chloralose / Q000008:administration & dosage / Q000009:adverse effects; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects; D007103:Immobilization / Q000009:adverse effects / Q000662:veterinary*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D009135:Muscular Diseases / Q000201:enzymology / Q000209:etiology / Q000628:therapy / Q000662:veterinary*; D026741:Physical Therapy Modalities / Q000662:veterinary; D012206:Rhabdomyolysis / Q000201:enzymology / Q000209:etiology / Q000628:therapy / Q000662:veterinary*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D006993:Hypnotics and Sedatives; D002698:Chloralose; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase